This early-stage study is testing a new combination treatment for HIV. It involves two lab-made antibodies and an immune system booster. The goal is to see if this combo is safe and can control the virus well enough for participants to safely stop their daily antiviral pills for …
Phase: PHASE1 • Sponsor: Rockefeller University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC